TD139

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Nscale’s IPO reveals $140.6m revenue against $1.02bn first-half loss

Anthropic is reportedly considering another advanced Claude model as competition with OpenAI intensifies across enterprise artificial-intelligence workloads. Representative image.

Anthropic weighs another Claude model as OpenAI Astra intensifies enterprise AI race

Arista Networks is expanding its EOS-based networking platform across 1.6-terabit Ethernet AI fabrics, hyperscale data centers, CloudVision and enterprise connectivity as artificial intelligence reshapes network architecture. Representative image.

Arista Networks company profile: How EOS and Ethernet are powering its AI data center expansion

Eli Lilly’s retatrutide moves closer to a planned 2027 U.S. filing after completing its core Phase 3 programme for obesity, knee pain and sleep apnea. Representative image.

Retatrutide development: Phase 3 results, 2027 FDA filing, TRIUMPH trials and what comes next

Galecto Biotech secures €79m in Series C funding to advance idiopathic pulmonary fibrosis treatment

Galecto Biotech, a Denmark-based pharmaceutical company specializing in galectin modulators for severe diseases like idiopathic pulmonary fibrosis (IPF)…

μFR system
αvβ6-integrin
α4β7 integrin
Þorgerður Katrín Gunnarsdóttir
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
ZYNRELEF

October 27, 2018